atrasentan has been researched along with Cirrhoses, Experimental Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, HQ; Rockey, DC; Weymouth, ND | 1 |
1 other study(ies) available for atrasentan and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease.
Topics: Animals; Atrasentan; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelins; Hypertension, Portal; Infusions, Intravenous; Liver; Liver Circulation; Liver Cirrhosis, Experimental; Male; Mice; Mice, Inbred C57BL; Portal Pressure; Pyrrolidines; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides; Time Factors; Vasoconstriction; Vasodilation | 2009 |